D. Medical, a medical device company that develops and manufactures insulin pumps, will see its quiet period end on . On August 4th, the company raised $10.5 million by offering 1.5 million shares at $7, below the range of $10-$12. Rodman & Renshaw acted as...read more
D. Medical, a medical device company that develops and manufactures insulin pumps, raised $11 million by offering 1.5 million shares at $7, below the range of $10-$12. D. Medical plans to list on the NASDAQ under the symbol DMED. Rodman & Renshaw acted as lead...read more
D. Medical, a medical device company that develops and manufactures insulin pumps, lowered the proposed deal size again for its upcoming IPO on Wednesday. The Israel-based company now plans to raise $12 million by offering 1.5 million shares at a price range of...read more
D. Medical, a medical device company that develops and manufactures insulin pumps, lowered the proposed deal size for its upcoming IPO on Tuesday. The Israel-based company now plans to raise $21 million by offering 1.88 million shares at a price range of...read more
D. Medical quiet period ends September 13
D. Medical, a medical device company that develops and manufactures insulin pumps, will see its quiet period end on . On August 4th, the company raised $10.5 million by offering 1.5 million shares at $7, below the range of $10-$12. Rodman & Renshaw acted as...read more
D. Medical prices IPO at $7.00, at the low end of the downwardly revised range
D. Medical, a medical device company that develops and manufactures insulin pumps, raised $11 million by offering 1.5 million shares at $7, below the range of $10-$12. D. Medical plans to list on the NASDAQ under the symbol DMED. Rodman & Renshaw acted as lead...read more
Deal size cut again for insulin pump provider D. Medical
D. Medical, a medical device company that develops and manufactures insulin pumps, lowered the proposed deal size again for its upcoming IPO on Wednesday. The Israel-based company now plans to raise $12 million by offering 1.5 million shares at a price range of...read more
D. Medical decreases proposed IPO deal size
D. Medical, a medical device company that develops and manufactures insulin pumps, lowered the proposed deal size for its upcoming IPO on Tuesday. The Israel-based company now plans to raise $21 million by offering 1.88 million shares at a price range of...read more